Development of Audio-Visual Health Education Media on Chemotherapy for Parents in Caring for Children with Acute Lymphoblastic Leukemia at Darussalam 3 Pediatric Unit, Al-Islam Hospital Bandung
DOI:
https://doi.org/10.31004/jn.v9i4.50147Abstract
Chemotherapy is considered the most effective treatment for children with Acute Lymphoblastic Leukemia (ALL) because it targets cancer cells that may have metastasized to other tissues. However, children undergoing chemotherapy experience both physical and psychological side effects, which also affect their parents. These impacts include changes in parental roles and responsibilities, limited knowledge about the disease, and the need for information to support independent care at home. This study aimed to develop audio-visual educational media on chemotherapy for parents of children with ALL based on their informational needs. A descriptive qualitative design with a Research and Development (R&D) approach was employed. Data were collected through in-depth interviews with seven parents, followed by the stages of initial planning, product development, and expert validation. Five major themes emerged: perceptions of chemotherapy, indications, side effects, management strategies, and educational media preferences. Expert validation by material and media specialists resulted in a feasibility score of 94.3%, categorized as highly appropriate. The study concludes that audio-visual educational media is feasible and effective as a health education tool to support parents in caring for their children during chemotherapy.Downloads
Published
2025-10-31
How to Cite
Maelah, S., Nurhasanah, R., Apriani, D., Inayah, I., & Nurjanah, N. (2025). Development of Audio-Visual Health Education Media on Chemotherapy for Parents in Caring for Children with Acute Lymphoblastic Leukemia at Darussalam 3 Pediatric Unit, Al-Islam Hospital Bandung. Jurnal Ners, 9(4), 7994–7999. https://doi.org/10.31004/jn.v9i4.50147
Issue
Section
Articles
License
Copyright (c) 2025 Jurnal Ners

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Authors who publish with this journal agree to the following terms: Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-ShareAlike 4.0 International License that allows others to share the work with an acknowledgement of the works authorship and initial publication in this journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journals published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).






